0001554289-16-000008.txt : 20161031
0001554289-16-000008.hdr.sgml : 20161031
20161031171712
ACCESSION NUMBER: 0001554289-16-000008
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20161031
DATE AS OF CHANGE: 20161031
EFFECTIVENESS DATE: 20161031
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: CURE PHARMACEUTICAL Corp
CENTRAL INDEX KEY: 0001554289
IRS NUMBER: 452717791
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-273536
FILM NUMBER: 161962514
BUSINESS ADDRESS:
STREET 1: 1620 BEACON PLACE
CITY: OXNARD
STATE: CA
ZIP: 93033
BUSINESS PHONE: 805 824 0410
MAIL ADDRESS:
STREET 1: 1620 BEACON PLACE
CITY: OXNARD
STATE: CA
ZIP: 93033
D
1
primary_doc.xml
X0707
D
LIVE
0001554289
CURE PHARMACEUTICAL Corp
1620 BEACON PLACE
OXNARD
CA
CALIFORNIA
93033
805 824 0410
CALIFORNIA
None
None
Corporation
true
Rob
Davidson
1620 Beacon Place
Oxnard
CA
CALIFORNIA
93033
Executive Officer
Director
Chief Executive Officer
Edward
Maliski
1620 Beacon Place
Oxnard
CA
CALIFORNIA
93033
Director
Vic
Branstetter
1620 Beacon Place
Oxnard
CA
CALIFORNIA
93033
Director
Wayne
Nasby
1620 Beacon Place
Oxnard
CA
CALIFORNIA
93033
Director
Ian
Sephton
1620 Beacon Place
Oxnard
CA
CALIFORNIA
93033
Director
Mark
Udell
1620 Beacon Place
Oxnard
CA
CALIFORNIA
93033
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
false
2015-11-10
false
true
true
true
Convertible Promissory Note
false
0
Colorado Financial Service Corp.
104343
None
None
304 Inverness Way South
Suite 355
Centennial
CO
COLORADO
80112
CA
CALIFORNIA
CT
CONNECTICUT
GA
GEORGIA
IL
ILLINOIS
IN
INDIANA
KY
KENTUCKY
MI
MICHIGAN
false
6033963
6033963
0
false
42
253334
0
In addition to the sales commission described above, the Company is required to issue warrants to purchase an aggregate of 141,142 shares of common stock of the Company at an exercise price of $1.00 per share.
0
false
CURE PHARMACEUTICAL Corp
Mark Udell
Mark Udell
CFO
2016-10-31